Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Working Capital Changes (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Other Working Capital Changes data on record, last reported at -$126000.0 in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 32.98% year-over-year to -$126000.0; the TTM value through Dec 2025 reached -$680000.0, up 7.48%, while the annual FY2025 figure was -$680000.0, 7.48% up from the prior year.
  • Other Working Capital Changes reached -$126000.0 in Q4 2025 per ARQT's latest filing, down from $464000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $12.7 million in Q1 2021 and bottomed at -$5.9 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is $350800.0, with a median of -$184000.0 recorded in 2024.
  • The widest YoY moves for Other Working Capital Changes: up 29548.84% in 2021, down 71350.0% in 2021.
  • A 5-year view of Other Working Capital Changes shows it stood at -$5.9 million in 2021, then skyrocketed by 131.78% to $1.9 million in 2022, then surged by 388.21% to $9.1 million in 2023, then tumbled by 102.06% to -$188000.0 in 2024, then surged by 32.98% to -$126000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$126000.0 in Q4 2025, $464000.0 in Q3 2025, and -$4.3 million in Q2 2025.